A-45507

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameA-45507
Drug Alias NameA-45507BA-45507AA-45507CA-45507
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLigases inhibitorsCell wall inhibitors
TargetsLigases
Therapy Area/IndicationsCandidiasisMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsCandidiasisMycoses

Other Information

ATC CodeN/A
Related LinksN/A